Virtu KCG Holdings’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$1.09M Sell
9,784
-9,171
-48% -$970K 0.03% 528
2017
Q1
$1.86M Buy
18,955
+12,901
+213% +$1.23M 0.05% 298
2016
Q4
$556K Sell
6,054
-3,370
-36% -$290K 0.01% 1380
2016
Q3
$798K Buy
9,424
+3,663
+64% +$308K 0.02% 913
2016
Q2
$469K Sell
5,761
-4,030
-41% -$307K 0.01% 1430
2016
Q1
$700K Buy
+9,791
New +$657K 0.02% 881
2015
Q4
Sell
-5,172
Closed -$318K 3564
2015
Q3
$318K Sell
5,172
-9,601
-65% -$671K 0.01% 2020
2015
Q2
$1.07M Sell
14,773
-1,254
-8% -$92.6K 0.02% 781
2015
Q1
$1.23M Buy
16,027
+8,378
+110% +$600K 0.03% 625
2014
Q4
$513K Sell
7,649
-5,804
-43% -$366K 0.01% 1662
2014
Q3
$816K Sell
13,453
-6,678
-33% -$411K 0.02% 1155
2014
Q2
$1.18M Buy
20,131
+14,728
+273% +$863K 0.02% 1014
2014
Q1
$313K Sell
5,403
-28,638
-84% -$1.53M ﹤0.01% 2464
2013
Q4
$1.82M Buy
34,041
+11,804
+53% +$700K 0.02% 729
2013
Q3
$1.37M Buy
+22,237
New +$1.33M 0.02% 886

Other funds holding DGX

Virtu KCG Holdings's DGX Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Quest Diagnostics (DGX) stake by 48% in Q2 2017, selling an estimated $970K and leaving 9,784 shares worth $1.09M. The position accounts for 0.03% of the portfolio, ranked #528.

Virtu KCG Holdings first reported a position in DGX in Q3 2013 and has held it in 15 quarters since. The position peaked at $1.86M in Q1 2017. 643 funds tracked by Wall St. Rank hold DGX as of Q2 2017.

  • Virtu KCG Holdings held 9,784 shares of Quest Diagnostics worth $1.09M as of Q2 2017.
  • Virtu KCG Holdings sold 9,171 Quest Diagnostics shares in Q2 2017, an estimated $970K.
  • Quest Diagnostics made up 0.03% of Virtu KCG Holdings's portfolio in Q2 2017, its #528 holding.
  • Virtu KCG Holdings first reported a position in Quest Diagnostics in Q3 2013 and has held it in 15 quarters since.
  • Virtu KCG Holdings's Quest Diagnostics position peaked at $1.86M in Q1 2017.
  • 643 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.